Get started
Author

Susan Foller

Observed names: Foller, Susan, S Foller, S. Foller
ORCID: 0000-0002-8086-9560
Observed ORCID: 0000-0002-8086-9560
OpenAlex ID: A5072904796
Supraphysiological androgen levels induce cellular senescence in human prostate cancer cells through the Src-Akt pathway
2014 · Julia Roediger, Wiebke Hessenkemper, et al. · Molecular Cancer · 88
PDF
Complementary and alternative medicine (CAM) supplements in cancer outpatients: analyses of usage and of interaction risks with cancer treatment
2021 · Clemens P. J. G. Wolf, Tobias Rachow, et al. · Journal of Cancer Research and Clinical Oncology · 56
PDF
Interactions in cancer treatment considering cancer therapy, concomitant medications, food, herbal medicine and other supplements
2021 · Clemens P. J. G. Wolf, Tobias Rachow, et al. · Journal of Cancer Research and Clinical Oncology · 55
PDF
Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as immunotherapeutic boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a multicentre, single-arm, phase 2 trial
2023 · Marc-Oliver Grimm, Emilio Esteban, et al. · The Lancet Oncology · 41
PDF
New First Line Treatment Options of Clear Cell Renal Cell Cancer Patients with PD-1 or PD-L1 Immune-Checkpoint Inhibitor-Based Combination Therapies
2020 · Marc-Oliver Grimm, Katharina Leucht, et al. · Journal of Clinical Medicine · 39
PDF
Focal bladder neck cautery associated with low rate of post-Aquablation bleeding.
2021 · Dean S Elterman, Susan Foller, et al. · PubMed · 35
Open versus robotic-assisted partial nephrectomy in patients with intermediate/high-complexity kidney tumours: final results of the randomised, controlled, open-label, multicentre trial OpeRa
2025 · M.-O. Grimm, J. Bedke, et al. · Annals of Oncology · 23
PDF
Rate, Factors, and Outcome of Delayed Graft Function After Kidney Transplantation of Deceased Donors
2021 · Laura Jahn, Christiane R..ster, et al. · Transplantation Proceedings · 22
Management of Immune-Related Adverse Events from Immune-Checkpoint Inhibitors in Advanced or Metastatic Renal Cell Carcinoma
2022 · Katharina Leucht, Nalyan Ali, et al. · Cancers · 21
PDF
Nebenwirkungen der Immun-Checkpoint-Inhibitoren
2017 · S. Foller, H. Oppel-Heuchel, et al. · Der Urologe · 21
Tailored immunotherapy approach with nivolumab with or without ipilimumab in patients with advanced transitional cell carcinoma after platinum-based chemotherapy (TITAN-TCC): a multicentre, single-arm, phase 2 trial
2023 · Marc-Oliver Grimm, Christine Barbara Grün, et al. · The Lancet Oncology · 17
Identification of bacteria in mixed infection from urinary tract of patient's samples using Raman analysis of dried droplets
2023 · Kateřina Aubrechtová Dragounová, Oleg Ryabchykov, et al. · The Analyst · 16
PDF
Risk Stratification and Treatment Algorithm of Metastatic Renal Cell Carcinoma
2021 · Marc-Oliver Grimm, Katharina Leucht, et al. · Journal of Clinical Medicine · 15
PDF
Rescue Allocation Modes in Eurotransplant Kidney Transplantation: Recipient Oriented Extended Allocation Versus Competitive Rescue Allocation—A Retrospective Multicenter Outcome Analysis
2023 · Volker Assfalg, Gregor Miller, et al. · Transplantation · 12
Therapie mit PD-1/PD-L1- und CTLA-4-Immun-Checkpoint-Inhibitoren: Immunvermittelte Nebenwirkungen
2018 · M.-O. Grimm, H. Oppel-Heuchel, et al. · Der Urologe · 11
Cabozantinib Plus Nivolumab in Adult Patients with Advanced or Metastatic Renal Cell Carcinoma: A Retrospective, Non-Interventional Study in a Real-World Cohort/GUARDIANS Project
2024 · Thomas Hilser, Christopher Darr, et al. · Cancers · 8
PDF
Nivolumab + Ipilimumab as Immunotherapeutic Boost in Metastatic Urothelial Carcinoma: A Nonrandomized Clinical Trial
2024 · Marc-Oliver Grimm, Martin Schostak, et al. · JAMA Oncology · 8
Prostate cancer treated with image-guided helical TomoTherapy® and image-guided LINAC-IMRT: Correlation between high-dose bladder volume, margin reduction, and genitourinary toxicity
2016 · Sonia Drozdz, Michael Schwedas, et al. · Strahlentherapie und Onkologie · 8
Nebenwirkungen der Immun-Checkpoint-Inhibitor-Therapie urologischer Tumoren
2021 · Marc-Oliver Grimm, Tobias Gottschlich, et al. · Der Urologe · 7
Prostate Imaging – An Update
2015 · T. Franiel, P. Asbach, et al. · RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · 7
Radical Prostatectomy in Kidney Transplant Recipients—A Multicenter Experience
2024 · Jacob Schmidt, Abdulbaki Yakac, et al. · European Urology Open Science · 6
67Ga-PSMA I&T for Radioguided Surgery of Lymph Node Metastases in Patients With Biochemical Recurrence of Prostate Cancer
2023 · Thomas Winkens, Frank Peter Berger, et al. · Clinical Nuclear Medicine · 5
Influence of Prostate Artery Embolization on Different Qualities of Lower Urinary Tract Symptoms Due to Benign Prostatic Obstruction
2022 · Anne Tabea Theurich, Lutz Leistritz, et al. · European Urology Focus · 5
Enfortumab vedotin plus pembrolizumab in metastatic urothelial carcinoma: First results on outcomes and safety in a German multicenter real-world patient cohort (GUARDIANS).
2025 · Stefanie Zschaebitz, Jozefina Casuscelli, et al. · Journal of Clinical Oncology · 4
Antikörper-Wirkstoff-Konjugate als neues Wirkprinzip in der Uroonkologie
2023 · Marc-Oliver Grimm, Susan Foller, et al. · Die Urologie · 4
Works count: 61
Citation count: 567
H-index: 13
I10-index: 15
Year
Topic
Type